| ［1］ |
Broccolo F, Drago F, Careddu AM, et al. Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus⁃6 and ⁃7［J］. J Invest Dermatol, 2005,124（6）:1234⁃1240. doi: 10.1111/j.0022⁃202X.2005.23719.x.
|
| ［2］ |
Drago F, Ciccarese G, Parodi A. Pityriasis rosea and pityriasis rosea⁃like eruptions: How to distinguish them?［J］. JAAD Case Rep, 2018,4（8）:800⁃801. doi: 10.1016/j.jdcr.2018.04.002.
|
| ［3］ |
Drago F, Ciccarese G, Javor S, et al. Vaccine⁃induced pityriasis rosea and pityriasis rosea⁃like eruptions: a review of the literature［J］. J Eur Acad Dermatol Venereol, 2016,30（3）:544⁃545. doi: 10.1111/jdv.12942.
|
| ［4］ |
Drago F, Ciccarese G, Rebora A, et al. Human herpesvirus⁃6, ⁃7, and Epstein⁃Barr virus reactivation in pityriasis rosea during COVID⁃19［J］. J Med Virol, 2021,93（4）:1850⁃1851. doi: 10. 1002/jmv.26549.
|
| ［5］ |
Ehsani AH, Nasimi M, Bigdelo Z. Pityriasis rosea as a cutaneous manifestation of COVID⁃19 infection［J］. J Eur Acad Dermatol Venereol, 2020,34（9）:e436⁃436e437. doi: 10.1111/jdv.16579.
|
| ［6］ |
Johansen M, Chisolm SS, Aspey LD, et al. Pityriasis rosea in otherwise asymptomatic confirmed COVID⁃19⁃positive patients: A report of 2 cases［J］. JAAD Case Rep, 2021,7:93⁃94. doi: 10. 1016/j.jdcr.2020.10.035.
|
| ［7］ |
Papakostas D, Stavropoulos PG, Papafragkaki D, et al. An atypical case of pityriasis rosea gigantea after influenza vaccination［J］. Case Rep Dermatol, 2014,6（1）:119⁃123. doi: 10. 1159/000362640.
|
